Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Okayama

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Kidney International|September 20, 2013
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney diseaseMasaru Matsui, Yukiji Takeda, Shiro Uemura, et al.
Scientific Reports|August 26, 2018
Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human StudyTomoya Nakano, Kenji Onoue, Yasuki Nakada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 16, 2009
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarctionYukiji Takeda, Shiro Uemura, Hajime Iwama, et al.
Journal of the American College of Cardiology|April 25, 2006
Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarctionHajime Iwama, Shiro Uemura, Noriyuki Naya, et al.
The American Journal of Cardiology|November 26, 2009
Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarctionKenji Onoue, Shiro Uemura, Yukiji Takeda, et al.
BMJ Open|December 18, 2019
Association between the number of board-certified cardiologists and the risk of in-hospital mortality: a nationwide study involving the Japanese registry of all cardiac and vascular diseasesKihei Yoneyama, Koshiro Kanaoka, Satoshi Okayama, et al.
Circulation|December 2, 2009
Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosisKenji Onoue, Shiro Uemura, Yukiji Takeda, et al.
Journal of the American Society of Nephrology : JASN|March 20, 2015
Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD StudyMasaru Matsui, Shiro Uemura, Yukiji Takeda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2021
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fractionHajime Fujimoto, Naofumi Doi, Satoshi Okayama, et al.
Circulation Reports|January 16, 2026
Wearable Device-Measured Physical Activity for Predicting Hospitalization-Associated Disability in Older Patients With Heart FailureYosuke Yoshida, Satoshi Okayama, Daisuke Fujihara, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Kidney International|September 20, 2013
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney diseaseMasaru Matsui, Yukiji Takeda, Shiro Uemura, et al.
Scientific Reports|August 26, 2018
Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human StudyTomoya Nakano, Kenji Onoue, Yasuki Nakada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 16, 2009
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarctionYukiji Takeda, Shiro Uemura, Hajime Iwama, et al.
Journal of the American College of Cardiology|April 25, 2006
Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarctionHajime Iwama, Shiro Uemura, Noriyuki Naya, et al.
The American Journal of Cardiology|November 26, 2009
Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarctionKenji Onoue, Shiro Uemura, Yukiji Takeda, et al.
BMJ Open|December 18, 2019
Association between the number of board-certified cardiologists and the risk of in-hospital mortality: a nationwide study involving the Japanese registry of all cardiac and vascular diseasesKihei Yoneyama, Koshiro Kanaoka, Satoshi Okayama, et al.
Circulation|December 2, 2009
Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosisKenji Onoue, Shiro Uemura, Yukiji Takeda, et al.
Journal of the American Society of Nephrology : JASN|March 20, 2015
Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD StudyMasaru Matsui, Shiro Uemura, Yukiji Takeda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2021
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fractionHajime Fujimoto, Naofumi Doi, Satoshi Okayama, et al.
Circulation Reports|January 16, 2026
Wearable Device-Measured Physical Activity for Predicting Hospitalization-Associated Disability in Older Patients With Heart FailureYosuke Yoshida, Satoshi Okayama, Daisuke Fujihara, et al.
Pageof 10